In comparison with Group 1, which consisted solely of tumor cells and CD8+ T cells, CD8+ T cells in Group 3 exhibited significantly enhanced cytotoxicity, effectively eliminating a larger number of tumor cells. The gene discussed is CD8A; the disease is neoplasm.